author-photo

Neeraj Agarwal

Huntsman Cancer Institute
University of Utah
All India Institute of Medical Sciences

762

Papers

13399

Citations

Citation Trend

Filter By

Papers (539) Sort By

Journal Conference Others

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (24)
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (2)
Abstract LB136: Targeting GCN2 kinase-driven stress response inactivation by orally available small molecules to restore immune tumor microenvironment in prostate cancers

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Differences in the genomic landscape of advanced prostate cancer (aPC) patients (pts) with BRCA1 versus BRCA2 mutations as detected by machine learning analysis of the comprehensive genomic profile (CGP) of cell-free DNA (cfDNA).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-world prevalence of homologous recombination repair gene (BRCA1/2 and ATM) mutations (HRRm) in patients (pts) with advanced prostate cancer (aPC) as detected by comprehensive genomic profiling (CGP) of circulating cell-free DNA (cfDNA).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Genomic predictors of response to PD-1 axis inhibitors in metastatic urothelial cancer (mUC) patients using machine learning analysis of tissue comprehensive genomic profiling (CGP).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
TALAPRO-3: A phase 3, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Techniques to avoid hypothermic circulatory arrest in the management of renal tumor with right atrium extension in children

2021 Indian Journal of Thoracic and Cardiovascular Surgery
Show All
- Source
- Cite
- Save
Citations (0)
513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)